Next Article in Journal
Retrospective and Prospective Surveillance and Clinical Presentation of Parvovirus B19 in Veneto, Italy, 2024
Previous Article in Journal
Uncovering the Host Range–Lifestyle Relationship in the Endophytic and Anthracnose Pathogenic Genus Colletotrichum
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

The Role of Clostridioides difficile Within the One Health Framework: A Review

by
Sotiris Alexiou
1,
Anastasia Diakou
2 and
Melania Kachrimanidou
1,*
1
Department of Microbiology, Medical School, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece
2
Laboratory of Parasitology and Parasitic Diseases, School of Veterinary Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece
*
Author to whom correspondence should be addressed.
Microorganisms 2025, 13(2), 429; https://doi.org/10.3390/microorganisms13020429
Submission received: 15 January 2025 / Revised: 12 February 2025 / Accepted: 13 February 2025 / Published: 16 February 2025
(This article belongs to the Section Medical Microbiology)

Abstract

:
Clostridioides difficile is the leading cause of antibiotic-associated diarrhea in hospitalized patients. In recent years, the incidence of C. difficile infection (CDI) has increased globally, with a notable rise in community-associated CDI (CA-CDI). The presence of the microorganism in animals, the environment, and food suggests that these sources may contribute to the spread of the infection in the community. This review applies a One Health approach, integrating human, animal, and environmental health, to provide a comprehensive strategy for understanding and managing this pathogen. Findings reveal the widespread dissemination of C. difficile in animals, the environment, and food. The predominant PCR ribotypes identified were RTs 078 and 014/020, followed by RTs 126, 001, 002, 009, 010, and 033. C. difficile strains exhibited resistance to multiple antimicrobial agents, including clindamycin, erythromycin, fluoroquinolones, cephalosporins, and tetracyclines. Discriminative typing methods, such as whole-genome sequencing, revealed clonal relationships between C. difficile strains from humans and animals, indicating either direct transmission or a common environmental source of infection. The high genetic similarity between isolates from the environment and humans indicates potential environmental contamination. Additionally, clusters of C. difficile strains found in food and humans indicate a possible foodborne transmission route. This review summarizes the current knowledge on the role of Clostridioides difficile within the One Health framework.

1. Introduction

Clostridioides difficile (formerly Clostridium difficile) is a Gram-positive, spore-forming, anaerobic bacterium that colonizes the gastrointestinal tract of humans and animals and is widely spread in the environment [1,2]. It is the primary cause of infectious diarrhea in hospitalized patients, with broad-spectrum antibiotics being the most significant risk factor for C. difficile infection (CDI), as they disrupt gut microbiota, allowing for spore germination and toxin production [3,4]. The pathogenesis of this microorganism is primarily mediated by two exotoxins, toxin A and toxin B, encoded in the pathogenicity locus (PaLoc) of the C. difficile genome [5]. Some C. difficile strains produce a third toxin, binary toxin (CDT), which is frequently observed in strains associated with the increased severity of C. difficile infection [6].
C. difficile infection can present with various clinical manifestations, ranging from mild diarrhea to severe and potentially fatal conditions, such as pseudomembranous colitis and toxic megacolon [7]. Historically, CDI was considered primarily a healthcare-associated infection (HA-CDI). HA-CDI is defined as CDI with symptom onset at least 48 h after hospital admission or within four weeks after hospital discharge [8]. In recent decades, the frequency, severity, recurrence rates, and mortality associated with CDI have significantly increased [9]. CDC’s most recent surveillance data report the crude overall incidence rate to be 116.1 cases per 100,000 persons, with a higher incidence of community associated cases (62.1 cases per 100,000 persons) compared with healthcare-associated cases (54.0 cases per 100,000) [10]. Alongside this, significant shifts in the global epidemiology of the disease have been observed, with the prevalence of community-associated CDI (CA-CDI) rising substantially [11]. CA-CDI is defined as a case of CDI with the onset of symptoms outside of healthcare facilities or within 48 h of admission to hospital or more than 12 weeks after [12]. CA-CDI accounts for approximately 33% of all CDI cases in Europe [13], with notable variation between countries. For instance, in Ireland, 38.4% of CDI cases are community-associated, while in the Netherlands, the proportion is 42.7%, and in Slovakia, it is 22.3%. Similarly, in Australia, 26% of CDI cases are community-associated [14]; whereas, in the USA, the percentage rises to 51% [15].
Investigations into potential community reservoirs for the pathogen reveal that C. difficile is widespread in animals, the environment, and food [16,17]. Specifically, the bacterium has been isolated from various animal species, including livestock, companion animals, horses, and wildlife [18]. Furthermore, it is found in diverse environments, such as soil, water, sewage, and various surfaces, and has also been detected in foods of both animal and plant origin [19].
The detection of identical C. difficile strains in humans, animals, food, and the environment suggests zoonotic transmission, with the environment and food acting as connecting links [20]. These findings underscore the need to study C. difficile within a One Health framework. The World Health Organization (WHO) defines One Health as an integrated, unifying approach that aims to sustainably balance and optimize the health of people, animals, and ecosystems, as illustrated in Figure 1 [21]. This approach fosters collaboration among various scientific fields, including medicine, veterinary science, biology, environmental science, and public health to address global issues, such as emerging infectious diseases, antimicrobial resistance, and food safety. For instance, Knight et al. applied the One Health concept in their study of C. difficile sequence type 11 (ST11) and 258 (a closely related lineage), analyzing isolates from humans, animals, and environmental sources across multiple continents [20]. Their findings emphasized zoonotic and anthroponotic transmission, highlighting the importance of an integrated approach to understanding and managing C. difficile spread and antimicrobial resistance.
The purpose of this study is to review the literature on the role of Clostridioides difficile within the One Health framework, with a particular focus on potential transmission events.

2. Clostridioides difficile in Animals

C. difficile has been isolated from a variety of animal species, including food-producing animals, household pets, and wildlife. The prevalence and main PCR ribotypes of C. difficile detected in these animals are summarized in Table 1.

2.1. Clostridioides difficile in Food-Producing Animals: Pigs

C. difficile has been extensively studied in pigs and is recognized as a significant pathogen, causing diarrhea primarily in piglets [22]. The detection of toxigenic strains in both healthy and sick pigs highlights the role of asymptomatic carriers as reservoirs of this pathogen [60]. Furthermore, the isolation of multiple C. difficile strains known to cause disease in humans suggests that neonatal pigs may serve as a potential reservoir for human C. difficile infections. PCR ribotype 078 was the predominant type identified in several studies [22,23,24,25,26], with RTs 014, 126, 033, 038, and 046 also frequently observed [20,27,28,29,30]. Some strains of C. difficile demonstrated antimicrobial resistance particularly to fluoroquinolones, cephalosporins, clindamycin, erythromycin, and tetracyclines [27,31]. Τhe most common PCR ribotypes have frequently been reported as resistant to some of these antibiotics; however, in some studies, the correlation between PCR ribotypes and resistance was either not investigated or not explicitly mentioned.
Dingle et al. found that 85% of the strains isolated from humans and pigs were genetically related, regardless of geographic location [61]. The use of tetracyclines in agriculture and animal farming has led to selective pressure, contributing to the evolution of tetracycline-resistant C. difficile RT078. The study also suggested that humans may acquire RT078 through the food chain or environmental exposure.
The whole-genome sequencing of forty C. difficile RT014 strains from pigs and humans in Australia revealed that twelve human isolates were genetically identical (≤2 SNVs) to six pig isolates [27]. These isolates were distributed across a large geographic area (~800 km), including both urban and rural areas, and over a long period of time (11–12 months), with 50% of human cases occurring without recent hospital exposure. Among human-derived C. difficile RT014 strains, non-susceptibility was observed to clindamycin, erythromycin, and ceftriaxone; whereas, pig-derived strains exhibited non-susceptibility to these antibiotics as well as to tetracycline [27]. These findings indicate a persistent community reservoir and interspecies transmission events. Although evidence of long-range interspecies transmission exists, the exact mode of transmission between pigs and humans remains unclear. Clostridium difficile infection (CDI) is a complex issue, and understanding the dynamics of CDI transmission, particularly in relation to the food chain and community environments, is still in its early stages. The continuous monitoring of C. difficile strains at both the molecular and phenotypic levels in humans, animals, food, and the environment is essential for identifying potential intervention points and reducing the overall burden of CDI.
A European study collected C. difficile RT078 strains from HA-CDI, CA-CDI, asymptomatic farmers, and pigs, revealing genetically related isolates (≤2 SNPs), primarily within countries and among different reservoirs [62]. In Dutch farms, isolates of RT078 from asymptomatic farmers and pigs were genetically identical (≤2 SNVs, ANI ≥99.73), forming clonal clusters and suggesting interspecies transmission [20,37].

2.2. Clostridioides difficile in Food-Producing Animals: Cattle

C. difficile has been isolated from both healthy cattle and cattle with diarrhea, with enteritis of preweaning neonatal calves being the most common CDI manifestation in this species [43]. The asymptomatic colonization of the gut by C. difficile is possible in healthy cattle, but the disruption of the gut microbiota, such as after antibiotic treatment, can lead to infection and diarrhea. Τhe detection of C. difficile has been associated with calves, antibiotic administration, and specific breeds, such as Limousin and Holstein [33,34,35,63]. The most frequently detected PCR ribotypes were 033, 126, 078, and 014/020 [2,26,30,34,35]. Many strains exhibited resistance to antibiotics, such as erythromycin, clindamycin, moxifloxacin, and tetracyclines [34,35,64]. For instance, Bandelj et al. reported high antimicrobial resistance in RT012 isolates, particularly against erythromycin, clindamycin, and rifampicin, while resistance to tetracycline was also observed [64]. Likewise, Masarikova et al. identified certain RT033 strains as multidrug-resistant, exhibiting resistance to ciprofloxacin, tetracycline, clindamycin, and moxifloxacin [34].
Some studies have reported identical strains of C. difficile in cattle and humans. An Italian study using the phylogenetic analysis of genomic DNA fingerprinting patterns from agarose-based PCR ribotyping found a 92% similarity between C. difficile RT078 strains from cattle and humans with CA-CDI [24]. In Australia, clonal groups (≤2 SNVs) were identified among C. difficile RTs 126, 127, and 033/288 from calf feces, carcasses, and both HA-CDI and CA-CDI cases [20]. Notably, an RT078 strain from cattle in Canada clustered with isolates from humans in the United Kingdom (ANI ≥ 99.75), suggesting the clonal spread of the pathogen across geographic boundaries [37]. This global dissemination could be facilitated by human movement, the international trade of animals and animal products, as well as by vectors, such as migratory birds.

2.3. Clostridioides difficile in Food-Producing Animals: Poultry

Data on C. difficile infection in poultry are limited, with cases reported in both asymptomatic animals and those presenting clinical disease. Frequently detected PCR ribotypes included 001, 002, 014/020 [26,38], and 078 [37,39], many of which are also found in humans. Berger et al. applied whole-genome sequencing and MLVA analysis, showing that RT025 isolates from humans, chickens, and soil samples, as well as RT084 isolates from humans and chickens, were genetically related [40]. The detected clusters for RT025 and RT084 among human, chicken, and soil isolates suggest a possible epidemiological connection, which could highlight a potential ongoing transmission between humans and environmental sources and may indicate zoonotic potential. Frentrup et al. reported a close phylogenetic relationship (≤2 SNPs) between C. difficile RT001 isolates from CDI patients, chicken manure, and chicken meat [38].

2.4. Clostridioides difficile in Food-Producing Animals: Goats and Sheep

Goats and sheep have been characterized primarily as asymptomatic carriers of C. difficile [16,43]. In sheep, RTs 126 and 078 were detected [24,41], while in goats, RTs 010, 014/020, 045, and 110 were identified [26,44]. Most PCR ribotypes isolated from small ruminants have also been detected in humans. Genetic analyses identified similarities between C. difficile RT078 strains from CA-CDI cases and sheep, suggesting interspecies transmission or shared environmental contamination [24].

2.5. Clostridioides difficile in Horses

C. difficile causes diarrhea in both foals and adult horses [16]. Frequently detected PCR ribotypes were RTs 033, 009, 010, 012 [45,46], 014/020 [30,46], 078 [26,37], 126 [26], and 127 [20]. In South Korea, C. difficile strains isolated from horse feces belonged to PCR ribotypes RT078, RT012, RT009, and RT010, exhibiting multidrug resistance to antibiotics such as cefotaxime, clindamycin, erythromycin, gentamycin, penicillin, and tetracycline [47]. Additionally, RT078 strains were also resistant to moxifloxacin, while RT012 and RT009 showed resistance to rifampicin. Higher isolation rates of the pathogen were associated with the age of the animals (foals under one year), antibiotic treatment, diarrhea, and the spring and summer seasons. A study in Australia conducted the whole-genome sequencing of RT012 strains from humans and horses, presenting further support the hypothesis that horses represent a possible reservoir for C. difficile dispersal to humans [46]. The SNP analysis identified three horse strains and one human strain differing by two SNPs, suggesting interspecies transmission or exposure to a common environmental source.

2.6. Clostridioides difficile in Household Pets: Dogs and Cats

The role of C. difficile in cases of the intestinal disease of companion animals remains unclear. Although infections in dogs have been documented [30], some studies reveal that dogs with diarrhea containing toxigenic C. difficile strains do not exhibit the typical macroscopic or microscopic lesions in the colon, associated with CDI [48]. Dogs frequently act as asymptomatic carriers of toxigenic and antimicrobial-resistant C. difficile strains. Resistance has been noted in clindamycin, erythromycin, moxifloxacin, tetracyclines, and occasionally, metronidazole [48,49,65,66]. Data on cats are limited, with the pathogen isolated from both healthy cats and those with diarrhea.
Beyond fecal samples, the pathogen has also been detected in other biological materials from dogs, such as nasal swabs, bronchoalveolar lavage fluid [67], and paw swabs [55,68]. While the potential significance of these findings for transmission routes remains unclear, the presence of C. difficile in these biological materials could represent a possible source of transmission, suggesting the need for further investigation into alternative modes of spread. The most common reported RTs in dogs included 014/020, 106, 010, 012, 078, and 001 [26,30,39,48,50]. Similarly, cats most frequently harbor RTs 010, 009, 014/020, 106, and 001 [49,52,53].
Close genetic relationships between C. difficile strains in companion animals and humans have been identified. Specifically, identical C. difficile ST8 strains (SNP = 1) were observed in a household dog and its owner with CDI [54]. In Denmark, cgMLST analysis revealed similarities (2–5 allelic differences) between strains isolated from dog feces and human clinical case strains, specifically belonging to RTs 014/020, 106/174, and two non-toxigenic strains (ST26) [50]. Finally, in Portugal, clusters of genetically identical RT 106 strains (SNPs ≤ 2) were identified, isolated from humans, dogs, and cats [49]. These findings indicate possible interspecies transmission or shared environmental contamination.

2.7. Clostridioides difficile in Wildlife

C. difficile has also been isolated from various wildlife species. In Canada, urban rats (Rattus norvegicus, Rattus rattus) were found to carry multiple PCR ribotypes, including 001, 078, 014, and 027 [56]. In the Netherlands, wild rodents (mice and rat species) and insectivores (shrew species) trapped in pig and cattle farms carried PCR ribotypes 005, 010, 014, 015, 078, and 087, which are associated with human CDI [57]. In Canada, mammals such as striped skunks (Mephitis mephitis) and Virginia opossums (Didelphis virginiana), trapped in pig farms and protected areas, were found to harbor toxigenic C. difficile strains in their feces, including RTs 078 and 002 [58]. Finally, a close phylogenetic relationship (≤2 SNVs) has been observed between C. difficile RT126 isolates from kangaroo feces and two human CDI cases in Australia [20].

3. Clostridioides difficile in the Environment

C. difficile has been isolated from soil [41,69], water [70,71], air [29], sewage [72,73], manure [64,74], compost [75,76], and various surfaces [55,77]. A wide range of PCR ribotypes has been identified, many of which are associated with human CDI. Notable RTs include 078 [23,37], 014/020 [35,64], 001, 002 [38], 126 [35,78], 046 [28,79], and 033 [35,64]. Prevalence rates vary significantly, from 0% in drinking water samples to as high as 100% in sewage samples [41]. The prevalence and main PCR ribotypes of C. difficile detected in various environmental sources are summarized in Table 2.

3.1. Clostridioides difficile in the Natural Environment

In the USA, Williamson et al. isolated the pathogen from water and soil samples [85]. SNP analysis revealed genomic overlap between isolates from dogs and soils (ST3-NT, ST15), as well as between environmental isolates (soil and water) and human clinical strains (ST42, ST3-T). Similarly, in Germany, strains isolated from lake sediment and wastewater inflows were closely related to human-derived strains (5–50 SNPs) [86]. These findings underscore the potential for transmission of the pathogen between humans and the environment.

3.2. Clostridioides difficile in the Livestock Farming Environment

A substantial number of environmental samples have been collected from livestock facilities. Alves et al. isolated C. difficile in pig farms from soil, manure, air, and wastewater samples, highlighting the potential for the airborne transmission of spores within farming facilities [29,41]. This suggests that airborne spores could contribute to the spread of C. difficile within farming environments, potentially affecting both animals and farm workers. Such transmission routes increase the risk of human exposure and cross-species transmission, which is significant for public health monitoring. Core genome SNV analysis revealed high genetic similarity between RT033-variant isolates from pigs and their surrounding environment. Additionally, the pathogen was isolated from samples of composted pig manure, including the hypervirulent RT078 strain, indicating that the use of composted manure on agriculture could facilitate the spread of the pathogen through the food chain [75]. In Sweden, RT046 was isolated from pigs, personnel clothing, soil, and stream water [28,79]. The stream strain was grouped with a human strain (≤2 cgMLST allelic differences) recovered three years earlier in a different geographic area. Most environmental and pig-derived strains were highly similar (≤6 cgMLST allelic differences), though they diverged from human strains. These findings suggest a potential link in the transmission of C. difficile between animals, humans, and the environment, highlighting the importance of tracking the pathogen across different reservoirs.

3.3. Clostridioides difficile in the Veterinary Clinic Environment

The environment of veterinary clinics has been identified as a potential reservoir for C. difficile. Villagomez-Estrada et al. reported that 4% of surface samples in a veterinary hospital in Spain tested positive for the pathogen, with PCR ribotypes 014 and 078 identified [80]. These strains were resistant to multiple antibiotics, including metronidazole, reflecting the extensive use of antibiotics in veterinary medicine. At a veterinary school in Poland, high contamination rates (96%) of C. difficile spores were observed on the soles of shoes of veterinarians, students, and support staff [81].

3.4. Clostridioides difficile in the Urban Environment

Urban environments also harbor C. difficile. In Spain, recreational sandboxes for children and dogs were found to be contaminated, with rates of 45% and 60%, respectively [82]. RTs 014, 009, and 039 were present in both types of samples; however, AFLP analysis indicated that these were distinct strains. In Australia, toxigenic C. difficile strains were detected in 58.5% of lawn samples from public areas [83]. The contamination of the lawn was likely related to the application of animal manure or human biosolids as fertilizer. Similarly, from the immediate outdoor environment of six hospitals in Australia, C. difficile was isolated from 60.4% of samples consisting of soil, sand, lawn, mulch, and mixed samples [87]. Toxigenic strains, which cause CDI in humans, were isolated, including RTs 014/020, 103, 056, 106, and 017.

3.5. Clostridioides difficile in the Household Environment

In Slovenia, identical PCR ribotypes were isolated from the slippers, shoes, and paw pads of dogs in three households. SNV analysis showed that RT014/020 strains were clonal within each household, suggesting a common source of contamination [68]. In Australia, C. difficile was recovered from manure, soil, compost, and shoe soles in 95.6% (22/23) of surveyed home gardens, with an overall isolation rate of 67% across all samples [74]. The widespread presence of spores was linked to the use of contaminated animal manure and compost as fertilizers. In this context, sodium hypochlorite at an alkaline pH has been shown to be effective in eliminating C. difficile spores [88].

3.6. Clostridioides difficile in Wastewater Treatment Plants

Wastewater treatment plants are significant sources of environmental contamination with C. difficile. Moradigaravand et al. highlighted the release of toxigenic C. difficile strains into surface waters, including lakes, rivers, and coastal areas, from eighteen wastewater treatment plants, ten of which received hospital wastewater [89]. SNP analysis revealed high similarity (≤2 SNPs) between clinical CDI strains and those isolated from wastewater. In Australia, C. difficile was found in twelve wastewater treatment plants, with prevalence rates ranging from 40% in irrigation water to 94.3% in biosolids [72]. PCR ribotypes associated with human CDI, such as RTs 014/020, 078, and 126, were commonly identified. Additionally, in Italy, MLVA analysis found identical C. difficile isolates in humans (RTs 011/018, 126), sewage (RTs 011/018, 126), and raw milk (RT011/018, new RT) (STRD ≤ 2) [2]. Similarly, Knight et al. reported the genetic clustering (≤2 SNVs) of C. difficile RT033 strains isolated from piglet feces, soil irrigated with wastewater effluent, and treated wastewater [20].

4. Clostridioides difficile in Foods

The presence of C. difficile has been investigated in various food types, including animal-derived foods (meat, seafood, dairy) and plant-derived foods (vegetables and grains). The prevalence and main PCR ribotypes of C. difficile detected in food are summarized in Table 3.

4.1. Clostridioides difficile in Animal-Derived Foods: Meat

Studies on C. difficile in meat have identified its presence in products such as pork, beef, and chicken, with the most frequently isolated PCR ribotypes being 078, 014/020, and 001 [90,91,92].
In an Australian study, the prevalence of the pathogen in calves younger than fourteen days was 25.3%, indicating that young slaughter age was a significant factor [36]. In a three-year surveillance study conducted in Slovenia, the pathogen was isolated from 3.4% of raw poultry, pork, and beef samples [90]. The detected RTs 001, 078, and 014/020 have also been isolated in CDI patients, animals, and the environment in Slovenia, highlighting the risk of foodborne transmission.
Rahimi et al. studied the pathogen in various types of raw meat, reporting the highest prevalence in buffalo and goat meat, while camel meat was negative for the pathogen [92]. The isolated strains belonged to RT078 and exhibited resistance to clindamycin, erythromycin, tetracyclines, ciprofloxacin, and gentamicin.
In Canada, C. difficile was isolated from frozen pork and beef samples, indicating that the pathogen’s spores can survive freezing [98]. In contrast, Pires et al. found no evidence of C. difficile in ready-to-eat meat samples, including beef, pork, chicken, and hamburgers [99].

4.2. Clostridioides difficile in Animal-Derived Foods: Seafood

Two studies in Italy examined the contamination of mussels and clams with C. difficile. Agnoletti et al. reported the pathogen in 11.6% of mussel and 23.2% of clam samples [93], while Troiano et al. identified it in 3.6% of mussels and 23.1% of clams [94]. The presence of the pathogen in seafood was not associated with bacterial indicators of fecal contamination in the water (e.g., Escherichia coli and Salmonella spp.) but reflected its widespread environmental presence. The most prevalent RTs from both studies were 014, 078, 126, 002, 010, and 018, many of which are frequently implicated in human CDI cases. Additionally, antimicrobial resistance was observed, particularly to erythromycin, clindamycin, and fluoroquinolones, with one strain exhibiting resistance to vancomycin. These findings suggest that bivalve mollusks could serve as a potential source of human infection.

4.3. Clostridioides difficile in Animal-Derived Foods: Dairy

C. difficile was recovered from raw bovine milk samples [2]. One strain belonged to a new RT, while others were identified as RTs 011/018 and 078. MLVA analysis revealed high genetic similarity between C. difficile RT011/018 strains from humans, raw bovine milk, and treated wastewater (STRD ≤ 1).

4.4. Clostridioides difficile in Plant-Derived Foods

The presence of C. difficile in plant-derived foods has mainly been studied in vegetables and grains. In a U.S. hospital, the pathogen was detected in a vegetable bread sample [100]. The strain belonged to RT027, and the positivity rate in vegetables was 0.1%. In three Italian hospitals, C. difficile was recovered from 1.9% of vegetable samples, with a positive sample from lettuce belonging to RT126 [95].
Tkalec et al. isolated C. difficile in 6.1% of raw vegetables in Slovenia [90]. Positive samples were found in lettuce, ready-to-eat salads, and root vegetables, with RTs 001, 012, and 010 identified. A European study investigating the prevalence of C. difficile in potato samples found a positivity rate of 22.4% across countries [96]. A statistically significant difference in C. difficile isolation was observed between soil-covered potatoes and visibly clean ones. The most prevalent PCR ribotypes were 078/126, 014/020, 010, and 023, which are frequently isolated from humans, animals, and the environment. Additionally, RT033 was isolated from a potato sample in Australia [20]. These findings suggest that potatoes could pose a public health risk. Finally, MLVA analysis grouped a human RT126 strain with an RT078 strain from a ready-to-eat salad (STRD = 6) [2].

5. Transmission Cycle of Clostridioides difficile

C. difficile is a well-established pathogen in healthcare settings and the leading cause of hospital-acquired diarrhea [101]. Within hospitals, the transmission of the pathogen occurs through direct contact with colonized patients or via contact with contaminated surfaces, materials, instruments, or medical personnel [102]. Recent studies have highlighted the role of asymptomatic carriers in hospital transmission, as patients arrive already colonized with the pathogen [103]. The continuous introduction of new C. difficile strains into hospitals underscores the critical role of community reservoirs, including animals, food, and the environment, in the transmission cycle. Clonal relationships observed among certain C. difficile strains indicate potential transmission between humans and animals or exposure to common environmental sources. Specifically, the direct transmission of the pathogen between humans and animals is likely in shared environments, such as households, farms, animal shelters, veterinary hospitals, zoos, and other settings where humans and animals coexist. However, direct transmission is rarely reported. For instance, Knetsch et al. demonstrated that asymptomatic farmers and pigs in Dutch swine farms were colonized with identical (SNP = 0) or nearly identical (≤2 SNPs) C. difficile RT078 strains, suggesting possible transmission between them [104]. Similarly, while direct transmission between companion animals and their owners has not been conclusively proven, a case study involved genetically identical C. difficile ST110 strains (related to RT020) in a 10-month-old infant and a dog, both with diarrhea [105].
Beyond direct fecal–oral transmission, C. difficile can spread over large geographic distances, via environmental and foodborne routes. Livestock colonized with C. difficile can contaminate meat during slaughter through the leakage of intestinal contents onto the carcass. Meat contamination can also occur during transport, storage, and processing [16]. The pathogen’s spores can survive recommended cooking temperatures (71 °C) for over two hours [106] and remain viable under refrigeration or freezing conditions [107]. Additionally, animal-derived foods, fruits, vegetables, and grains can become contaminated with C. difficile through certain agricultural practices. The application of fertilizers derived from animal manure, compost products, or human biosolids can introduce C. difficile to crops [72,75]. Additionally, the use of treated wastewater for agricultural irrigation can disperse C. difficile spores onto crops [72]. Treated wastewater flowing into surface waters can contaminate lakes, seas, and rivers, as well as fish and edible bivalves living in these aquatic ecosystems [89]. Currently, there are no documented cases of CDI resulting from the consumption of contaminated food. Therefore, C. difficile is considered an unspecified foodborne agent, and further research is needed to evaluate the viability of its spores and the growth potential of the microorganism in foods [108].
Other transmission routes, such as airborne dissemination or vectors like birds, rodents, and arthropods, can spread the pathogen across large geographic areas [29,109]. As previously discussed, airborne spores collected from swine units tested positive for C. difficile, supporting the possibility of airborne transmission, while vermin in swine units were found to carry C. difficile PCR ribotypes 078 and 045, suggesting a role in the spread of the pathogen.
Finally, the natural environment has been identified as a natural reservoir for the microorganism, carrying highly divergent strains capable of infecting humans and animals, who, in turn, excrete C. difficile spores through their feces, thus perpetuating the transmission cycle [71].

6. Conclusions

This review confirms that Clostridioides difficile is a critical pathogen within the One Health framework. The application of high-resolution microbial genomics, integrating data from clinical, veterinary, and environmental sources, serves as an ideal model for advancing the understanding of epidemiological and genetic factors contributing to the emergence, evolution, and spread of CDI [110].
Current strategies for controlling C. difficile primarily focus on antibiotic stewardship and infection control policies within healthcare settings [111]. Reducing antibiotic use in agriculture and livestock is also critical. In this context, administering non-toxigenic C. difficile strains, such as strain Z31, has shown promise in reducing CDI incidence in piglets [112].
Mitigating environmental contamination is another priority. Vaccine development aimed at reducing colonization and infection in both animals and humans is under consideration [113]. Composting biosolids and the anaerobic digestion of sewage sludge have been effective in reducing C. difficile levels, though the complete elimination of the pathogen remains challenging [17]. Additionally, heating foods to temperatures above 85 °C is recommended to prevent ingestion of C. difficile spores through contaminated food [114]. Enhancing host resistance to CDI by modulating the gut microbiome also represents a promising therapeutic approach [17,43].
Finally, standardizing culture and PCR ribotyping methods for this microorganism, establishing a comprehensive PCR ribotype library, and adopting a unified ISO procedure for isolating C. difficile from food products are essential steps for conducting effective global surveillance studies on this pathogen [108,115].

Author Contributions

S.A.: writing—original draft preparation. A.D. and M.K.: writing—review and editing. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Data Availability Statement

No new data were created or analyzed in this study. Data sharing is not applicable to this article.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Smits, W.K.; Lyras, D.; Lacy, D.B.; Wilcox, M.H.; Kuijper, E.J. Clostridium difficile infection. Nat. Rev. Dis. Primers 2016, 2, 16020. [Google Scholar] [CrossRef]
  2. Romano, V.; Pasquale, V.; Lemee, L.; El Meouche, I.; Pestel-Caron, M.; Capuano, F.; Buono, P.; Dumontet, S. Clostridioides difficile in the environment, food, animals and humans in southern Italy: Occurrence and genetic relatedness. Comp. Immunol. Microbiol. Infect. Dis. 2018, 59, 41–46. [Google Scholar] [CrossRef] [PubMed]
  3. Rafey, A.; Jahan, S.; Farooq, U.; Akhtar, F.; Irshad, M.; Nizamuddin, S.; Parveen, A. Antibiotics Associated with Clostridium difficile Infection. Cureus 2023, 15, e39029. [Google Scholar] [CrossRef]
  4. Sehgal, K.; Khanna, S. Gut microbiome and Clostridioides difficile infection: A closer look at the microscopic interface. Ther. Adv. Gastroenterol. 2021, 14, 1756284821994736. [Google Scholar] [CrossRef] [PubMed]
  5. Di Bella, S.; Ascenzi, P.; Siarakas, S.; Petrosillo, N.; Di Masi, A. Clostridium difficile Toxins A and B: Insights into Pathogenic Properties and Extraintestinal Effects. Toxins 2016, 8, 134. [Google Scholar] [CrossRef]
  6. Gerding, D.N.; Johnson, S.; Rupnik, M.; Aktories, K. Clostridium difficile binary toxin CDT: Mechanism, epidemiology, and potential clinical importance. Gut Microbes 2014, 5, 15–27. [Google Scholar] [CrossRef]
  7. Czepiel, J.; Dróżdż, M.; Pituch, H.; Kuijper, E.J.; Perucki, W.; Mielimonka, A.; Goldman, S.; Wultańska, D.; Garlicki, A.; Biesiada, G. Clostridium difficile infection: Review. Eur. J. Clin. Microbiol. Infect. Dis. 2019, 38, 1211–1221. [Google Scholar] [CrossRef] [PubMed]
  8. Ragusa, R.; Giorgianni, G.; Lupo, L.; Sciacca, A.; Rametta, S.; La Verde, M.; Mulè, S.; Marranzano, M. Healthcare-associated Clostridium difficile infection: Role of correct hand hygiene in cross-infection control. J. Prev. Med. Hyg. 2018, 59, E145–E152. [Google Scholar]
  9. Vindigni, S.M.; Surawicz, C.M. C. difficile Infection: Changing Epidemiology and Management Paradigms. Clin. Transl. Gastroenterol. 2015, 6, e99. [Google Scholar] [CrossRef] [PubMed]
  10. Centers for Disease Control and Prevention. Emerging Infections Program, Healthcare-Associated Infections—Community Interface Surveillance Report, Clostridioides difficile Infection (CDI). 2022. Available online: https://www.cdc.gov/healthcare-associated-infections/media/pdfs/2022-CDI-Report-508.pdf (accessed on 1 February 2025).
  11. Khanna, S.; Pardi, D.S.; Aronson, S.L.; Kammer, P.P.; Orenstein, R.; St Sauver, J.L.S.; Harmsen, S.W.; Zinsmeister, A.R. The epidemiology of community-acquired Clostridium difficile infection: A population-based study. Am. J. Gastroenterol. 2012, 107, 89–95. [Google Scholar] [CrossRef] [PubMed]
  12. European Centre for Disease Prevention and Control. European Surveillance of Clostridioides (Clostridium) difficile Infections: Surveillance Protocol Version 2.4: ECDC. 2019. Available online: https://www.ecdc.europa.eu/sites/default/files/documents/clostridium-difficile-infections-EU-surveillance-protocol-vers2.4.pdf (accessed on 1 February 2025).
  13. Liu, C.; Monaghan, T.; Yadegar, A.; Louie, T.; Kao, D. Insights into the Evolving Epidemiology of Clostridioides difficile Infection and Treatment: A Global Perspective. Antibiotics 2023, 12, 1141. [Google Scholar] [CrossRef] [PubMed]
  14. Slimings, C.; Armstrong, P.; Beckingham, W.D.; Bull, A.L.; Hall, L.; Kennedy, K.J.; Marquess, J.; McCann, R.; Menzies, A.; Mitchell, B.G.; et al. Increasing incidence of Clostridium difficile infection, Australia, 2011–2012. Med. J. Aust. 2014, 200, 272–276. [Google Scholar] [CrossRef] [PubMed]
  15. Younas, M.; Royer, J.; Weissman, S.B.; Waites, K.S.; Dash, S.; Rac, H.; Bookstaver, P.B.; Justo, J.A.; Bell, L.; Maki, A.; et al. Burden of community-associated Clostridioides difficile infection in southeastern United States: A population-based study. Infection 2020, 48, 129–132. [Google Scholar] [CrossRef] [PubMed]
  16. Rodriguez, C.; Taminiau, B.; Van Broeck, J.; Delmée, M.; Daube, G. Clostridium difficile in Food and Animals: A Comprehensive Review. Adv. Exp. Med. Biol. 2016, 932, 65–92. [Google Scholar] [CrossRef]
  17. Warriner, K.; Xu, C.; Habash, M.; Sultan, S.; Weese, S.J. Dissemination of Clostridium difficile in food and the environment: Significant sources of C. difficile community-acquired infection? J. Appl. Microbiol. 2017, 122, 542–553. [Google Scholar] [CrossRef] [PubMed]
  18. Weese, J.S. Clostridium (Clostridioides) difficile in animals. J. Veter-Diagn. Investig. 2020, 32, 213–221. [Google Scholar] [CrossRef]
  19. Bolton, D.; Marcos, P. The Environment, Farm Animals and Foods as Sources of Clostridioides difficile Infection in Humans. Foods 2023, 12, 1094. [Google Scholar] [CrossRef]
  20. Knight, D.R.; Kullin, B.; Androga, G.O.; Barbut, F.; Eckert, C.; Johnson, S.; Spigaglia, P.; Tateda, K.; Tsai, P.-J.; Riley, T.V. Evolutionary and Genomic Insights into Clostridioides difficile Sequence Type 11: A Diverse Zoonotic and Antimicrobial-Resistant Lineage of Global One Health Importance. mBio 2019, 10, e00446-19. [Google Scholar] [CrossRef] [PubMed]
  21. One Health High-Level Expert Panel (OHHLEP); Adisasmito, W.B.; Almuhairi, S.; Behravesh, C.B.; Bilivogui, P.; Bukachi, S.A.; Casas, N.; Becerra, N.C.; Charron, D.F.; Chaudhary, A.; et al. One Health: A new definition for a sustainable and healthy future. PLoS Pathog. 2022, 18, e1010537. [Google Scholar] [CrossRef]
  22. Kim, H.-Y.; Cho, A.; Kim, J.W.; Kim, H.; Kim, B. High prevalence of Clostridium difficile PCR ribotype 078 in pigs in Korea. Anaerobe 2018, 51, 42–46. [Google Scholar] [CrossRef]
  23. O’shaughnessy, R.A.; Habing, G.G.; Gebreyes, W.A.; Bowman, A.S.; Weese, J.S.; Rousseau, J.; Stull, J.W. Clostridioides difficile on Ohio swine farms (2015): A comparison of swine and human environments and assessment of on-farm risk factors. Zoonoses Public Health 2019, 66, 861–870. [Google Scholar] [CrossRef]
  24. Tramuta, C.; Spigaglia, P.; Barbanti, F.; Bianchi, D.M.; Boteva, C.; Di Blasio, A.; Zoppi, S.; Zaccaria, T.; Proroga, Y.T.R.; Chiavacci, L.; et al. Comparison of Clostridioides difficile strains from animals and humans: First results after introduction of C. difficile molecular typing and characterization at the Istituto Zooprofilattico Sperimentale of Piemonte, Liguria e Valle d’Aosta, Italy. Comp. Immunol. Microbiol. Infect. Dis. 2021, 75, 101623. [Google Scholar] [CrossRef] [PubMed]
  25. Krutova, M.; Zouharova, M.; Matejkova, J.; Tkadlec, J.; Krejčí, J.; Faldyna, M.; Nyc, O.; Bernardy, J. The emergence of Clostridium difficile PCR ribotype 078 in piglets in the Czech Republic clusters with Clostridium difficile PCR ribotype 078 isolates from Germany, Japan and Taiwan. Int. J. Med. Microbiol. 2018, 308, 770–775. [Google Scholar] [CrossRef] [PubMed]
  26. Janezic, S.; Zidaric, V.; Pardon, B.; Indra, A.; Kokotovic, B.; Blanco, J.L.; Seyboldt, C.; Diaz, C.R.; Poxton, I.R.; Perreten, V.; et al. International Clostridium difficile animal strain collection and large diversity of animal associated strains. BMC Microbiol. 2014, 14, 173. [Google Scholar] [CrossRef] [PubMed]
  27. Knight, D.R.; Squire, M.M.; Collins, D.A.; Riley, T.V. Genome Analysis of Clostridium difficile PCR Ribotype 014 Lineage in Australian Pigs and Humans Reveals a Diverse Genetic Repertoire and Signatures of Long-Range Interspecies Transmission. Front. Microbiol. 2016, 7, 2138. [Google Scholar] [CrossRef] [PubMed]
  28. Norén, T.; Johansson, K.; Unemo, M. Clostridium difficile PCR ribotype 046 is common among neonatal pigs and humans in Sweden. Clin. Microbiol. Infect. 2014, 20, O2–O6. [Google Scholar] [CrossRef] [PubMed]
  29. Alves, F.; Cano, M.; Brondani, G.; Nunes, A.; Oleastro, M. Airborne spores’ dissemination of a swine associated Clostridioides difficile clone. Anaerobe 2022, 78, 102651. [Google Scholar] [CrossRef] [PubMed]
  30. Silva, R.O.S.; Rupnik, M.; Diniz, A.N.; Vilela, E.G.; Lobato, F.C.F. Clostridium difficile ribotypes in humans and animals in Brazil. Mem. Inst. Oswaldo Cruz 2015, 110, 1062–1065. [Google Scholar] [CrossRef]
  31. Cho, A.; Byun, J.-W.; Kim, J.W.; Oh, S.-I.; Lee, M.-H.; Kim, H.-Y. Low Prevalence of Clostridium difficile in Slaughter Pigs in Korea. J. Food Prot. 2015, 78, 1034–1036. [Google Scholar] [CrossRef] [PubMed]
  32. Putsathit, P.; Neela, V.K.; Joseph, N.M.; Ooi, P.T.; Ngamwongsatit, B.; Knight, D.R.; Riley, T.V. Molecular epidemiology of Clostridium difficile isolated from piglets. Veter-Microbiol. 2019, 237, 108408. [Google Scholar] [CrossRef] [PubMed]
  33. Spigaglia, P.; Barbanti, F.; Faccini, S.; Vescovi, M.; Criscuolo, E.M.; Ceruti, R.; Gaspano, C.; Rosignoli, C. Clostridioides difficile in Pigs and Dairy Cattle in Northern Italy: Prevalence, Characterization and Comparison between Animal and Human Strains. Microorganisms 2023, 11, 1738. [Google Scholar] [CrossRef] [PubMed]
  34. Masarikova, M.; Simkova, I.; Plesko, M.; Eretova, V.; Krutova, M.; Cizek, A. The Colonisation of Calves in Czech Large-Scale Dairy Farms by Clonally-Related Clostridioides difficile of the Sequence Type 11 Represented by Ribotypes 033 and 126. Microorganisms 2020, 8, 901. [Google Scholar] [CrossRef]
  35. Blasi, F.; Lovito, C.; Albini, E.; Bano, L.; Dalmonte, G.; Drigo, I.; Maresca, C.; Massacci, F.R.; Orsini, S.; Primavilla, S.; et al. Clostridioides difficile in Calves in Central Italy: Prevalence, Molecular Typing, Antimicrobial Susceptibility and Association with Antibiotic Administration. Animals 2021, 11, 515. [Google Scholar] [CrossRef] [PubMed]
  36. Knight, D.; Putsathit, P.; Elliott, B.; Riley, T. Contamination of Australian newborn calf carcasses at slaughter with Clostridium difficile. Clin. Microbiol. Infect. 2016, 22, 266.e1–266.e7. [Google Scholar] [CrossRef] [PubMed]
  37. Knetsch, C.W.; Kumar, N.; Forster, S.C.; Connor, T.R.; Browne, H.P.; Harmanus, C.; Sanders, I.M.; Harris, S.R.; Turner, L.; Morris, T.; et al. Zoonotic Transfer of Clostridium difficile Harboring Antimicrobial Resistance between Farm Animals and Humans. J. Clin. Microbiol. 2018, 56, e01384-17. [Google Scholar] [CrossRef] [PubMed]
  38. Frentrup, M.; Thiel, N.; Junker, V.; Behrens, W.; Münch, S.; Siller, P.; Kabelitz, T.; Faust, M.; Indra, A.; Baumgartner, S.; et al. Agricultural fertilization with poultry manure results in persistent environmental contamination with the pathogen Clostridioides difficile. Environ. Microbiol. 2021, 23, 7591–7602. [Google Scholar] [CrossRef]
  39. Álvarez-Pérez, S.; Blanco, J.L.; Harmanus, C.; Kuijper, E.; García, M.E. Subtyping and antimicrobial susceptibility of Clostridium difficile PCR ribotype 078/126 isolates of human and animal origin. Veter-Microbiol. 2017, 199, 15–22. [Google Scholar] [CrossRef] [PubMed]
  40. Berger, F.K.; Mellmann, A.; Bischoff, M.; von Müller, L.; Becker, S.L.; Simango, C.; Gärtner, B. Molecular epidemiology and antimicrobial resistance of Clostridioides difficile detected in chicken, soil and human samples from Zimbabwe. Int. J. Infect. Dis. 2020, 96, 82–87. [Google Scholar] [CrossRef]
  41. Alves, F.; Nunes, A.; Castro, R.; Sequeira, A.; Moreira, O.; Matias, R.; Rodrigues, J.C.; Silveira, L.; Gomes, J.P.; Oleastro, M. Assessment of the Transmission Dynamics of Clostridioides difficile in a Farm Environment Reveals the Presence of a New Toxigenic Strain Connected to Swine Production. Front. Microbiol. 2022, 13, 858310. [Google Scholar] [CrossRef]
  42. Abdel-Glil, M.Y.; Thomas, P.; Schmoock, G.; Abou-El-Azm, K.; Wieler, L.H.; Neubauer, H.; Seyboldt, C. Presence of Clostridium difficile in poultry and poultry meat in Egypt. Anaerobe 2018, 51, 21–25. [Google Scholar] [CrossRef] [PubMed]
  43. Kachrimanidou, M.; Tzika, E.; Filioussis, G. Clostridioides (Clostridium) difficile in Food-Producing Animals, Horses and Household Pets: A Comprehensive Review. Microorganisms 2019, 7, 667. [Google Scholar] [CrossRef] [PubMed]
  44. Álvarez-Pérez, S.; Blanco, J.L.; Martínez-Nevado, E.; Peláez, T.; Harmanus, C.; Kuijper, E.; García, M.E. Shedding of Clostridium difficile PCR ribotype 078 by zoo animals, and report of an unstable metronidazole-resistant isolate from a zebra foal (Equus quagga burchellii). Veter-Microbiol. 2014, 169, 218–222. [Google Scholar] [CrossRef]
  45. Kecerova, Z.; Cizek, A.; Nyc, O.; Krutova, M. Clostridium difficile isolates derived from Czech horses are resistant to enrofloxacin; cluster to clades 1 and 5 and ribotype 033 predominates. Anaerobe 2019, 56, 17–21. [Google Scholar] [CrossRef] [PubMed]
  46. Hain-Saunders, N.M.R.; Knight, D.R.; Bruce, M.; Byrne, D.; Riley, T.V. Genomic Analysis of Clostridioides difficile Recovered from Horses in Western Australia. Microorganisms 2023, 11, 1743. [Google Scholar] [CrossRef]
  47. Lee, Y.-R.; Lee, K.; Byun, J.-W.; Kim, H.; So, B.; Ku, B.-K.; Kim, H.-Y.; Moon, B.-Y. Prevalence, genetic characteristics, and antimicrobial resistance of Clostridioides difficile isolates from horses in Korea. Anaerobe 2023, 80, 102700. [Google Scholar] [CrossRef]
  48. Leite, S.; Cotias, C.; Rainha, K.C.; Gil Santos, M.; Penna, B.F.; Moraes, R.F.; Harmanus, C.; Smits, W.K.; Ferreira, E.d.O. Prevalence of Clostridioides difficile in dogs (Canis familiaris) with gastrointestinal disorders in Rio de Janeiro. Anaerobe 2023, 83, 102765. [Google Scholar] [CrossRef] [PubMed]
  49. Alves, F.; Castro, R.; Pinto, M.; Nunes, A.; Pomba, C.; Oliveira, M.; Silveira, L.; Gomes, J.P.; Oleastro, M. Molecular epidemiology of Clostridioides difficile in companion animals: Genetic overlap with human strains and public health concerns. Front. Public Health 2022, 10, 1070258. [Google Scholar] [CrossRef] [PubMed]
  50. Bjöersdorff, O.G.; Lindberg, S.; Kiil, K.; Persson, S.; Guardabassi, L.; Damborg, P. Dogs are carriers of Clostridioides difficile lineages associated with human community-acquired infections. Anaerobe 2021, 67, 102317. [Google Scholar] [CrossRef]
  51. Viegas, F.M.; Ramos, C.P.; Xavier, R.G.C.; Lopes, E.O.; Júnior, C.A.O.; Bagno, R.M.; Diniz, A.N.; Lobato, F.C.F.; Silva, R.O.S. Fecal shedding of Salmonella spp., Clostridium perfringens, and Clostridioides difficile in dogs fed raw meat-based diets in Brazil and their owners’ motivation. PLoS ONE 2020, 15, e0231275. [Google Scholar] [CrossRef] [PubMed]
  52. Albuquerque, C.; Pagnossin, D.; Landsgaard, K.; Simpson, J.; Brown, D.; Irvine, J.; Candlish, D.; Ridyard, A.E.; Douce, G.; Millins, C. The duration of antibiotic treatment is associated with carriage of toxigenic and non-toxigenic strains of Clostridioides difficile in dogs. PLoS ONE 2021, 16, e0245949. [Google Scholar] [CrossRef] [PubMed]
  53. Rabold, D.; Espelage, W.; Abu Sin, M.; Eckmanns, T.; Schneeberg, A.; Neubauer, H.; Möbius, N.; Hille, K.; Wieler, L.H.; Seyboldt, C.; et al. The zoonotic potential of Clostridium difficile from small companion animals and their owners. PLoS ONE 2018, 13, e0193411. [Google Scholar] [CrossRef] [PubMed]
  54. Redding, L.E.; Habing, G.G.; Tu, V.; Bittinger, K.L.; O’Day, J.; Pancholi, P.; Wang, S.; Alexander, A.; Kelly, B.J.; Weese, J.S.; et al. Infrequent intrahousehold transmission of Clostridioides difficile between pet owners and their pets. Zoonoses Public Health 2023, 70, 341–351. [Google Scholar] [CrossRef] [PubMed]
  55. Alam, M.J.; McPherson, J.; Miranda, J.; Thrall, A.; Ngo, V.; Kessinger, R.; Begum, K.; Marin, M.; Garey, K.W. Molecular epidemiology of Clostridioides difficile in domestic dogs and zoo animals. Anaerobe 2019, 59, 107–111. [Google Scholar] [CrossRef] [PubMed]
  56. Himsworth, C.G.; Patrick, D.M.; Mak, S.; Jardine, C.M.; Tang, P.; Weese, J.S. Carriage of Clostridium difficile by Wild Urban Norway Rats (Rattus norvegicus) and Black Rats (Rattus rattus). Appl. Environ. Microbiol. 2014, 80, 1299–1305. [Google Scholar] [CrossRef] [PubMed]
  57. Krijger, I.M.; Meerburg, B.G.; Harmanus, C.; Burt, S.A. Clostridium difficile in wild rodents and insectivores in the Netherlands. Lett. Appl. Microbiol. 2019, 69, 35–40. [Google Scholar] [CrossRef] [PubMed]
  58. Bondo, K.J.; Pearl, D.L.; Janecko, N.; Reid-Smith, R.J.; Parmley, E.J.; Weese, J.S.; Rousseau, J.; Taboada, E.; Mutschall, S.; Jardine, C.M. Salmonella, Campylobacter, Clostridium difficile, and anti-microbial resistant Escherichia coli in the faeces of sympatric meso-mammals in southern Ontario, Canada. Zoonoses Public Health 2019, 66, 406–416. [Google Scholar] [CrossRef] [PubMed]
  59. Zlender, T.; Golob, Z.; Rupnik, M. Low Clostridioides difficile positivity rate in wild animal shelter in Slovenia. Anaerobe 2022, 77, 102643. [Google Scholar] [CrossRef]
  60. Knight, D.R.; Squire, M.M.; Riley, T.V. Nationwide surveillance study of Clostridium difficile in Australian neonatal pigs shows high prevalence and heterogeneity of PCR Ribotypes. Appl. Environ. Microbiol. 2015, 81, 119–123. [Google Scholar] [CrossRef] [PubMed]
  61. Dingle, K.E.; Didelot, X.; Quan, T.P.; Eyre, D.W.; Stoesser, N.; Marwick, C.A.; Coia, J.; Brown, D.; Buchanan, S.; Ijaz, U.Z.; et al. A Role for Tetracycline Selection in Recent Evolution of Agriculture-Associated Clostridium difficile PCR Ribotype 078. mBio 2019, 10, e02790-18. [Google Scholar] [CrossRef]
  62. Moloney, G.; Eyre, D.W.; Mac Aogáin, M.; McElroy, M.C.; Vaughan, A.; Peto, T.E.; Crook, D.W.; Rogers, T.R. Human and Porcine Transmission of Clostridioides difficile Ribotype 078, Europe. Emerg. Infect. Dis. 2021, 27, 2294–2300. [Google Scholar] [CrossRef] [PubMed]
  63. Rodriguez, C.; Hakimi, D.-E.; Vanleyssem, R.; Taminiau, B.; Van Broeck, J.; Delmée, M.; Korsak, N.; Daube, G. Clostridium difficile in beef cattle farms, farmers and their environment: Assessing the spread of the bacterium. Veter-Microbiol. 2017, 210, 183–187. [Google Scholar] [CrossRef]
  64. Bandelj, P.; Golob, M.; Ocepek, M.; Zdovc, I.; Vengust, M. Antimicrobial Susceptibility Patterns of Clostridium difficile Isolates from Family Dairy Farms. Zoonoses Public Health 2017, 64, 213–221. [Google Scholar] [CrossRef] [PubMed]
  65. Finsterwalder, S.; Loncaric, I.; Cabal, A.; Szostak, M.; Barf, L.; Marz, M.; Allerberger, F.; Burgener, I.; Tichy, A.; Feßler, A.; et al. Dogs as carriers of virulent and resistant genotypes of Clostridioides difficile. Zoonoses Public Health 2022, 69, 673–681. [Google Scholar] [CrossRef]
  66. Andrés-Lasheras, S.; Martín-Burriel, I.; Mainar-Jaime, R.C.; Morales, M.; Kuijper, E.; Blanco, J.L.; Chirino-Trejo, M.; Bolea, R. Preliminary studies on isolates of Clostridium difficile from dogs and exotic pets. BMC Vet. Res. 2018, 14, 77. [Google Scholar] [CrossRef]
  67. Rodriguez, C.; Taminiau, B.; Bouchafa, L.; Romijn, S.; Rajamäki, M.; Van Broeck, J.; Delmée, M.; Clercx, C.; Daube, G. Clostridium difficile beyond stools: Dog nasal discharge as a possible new vector of bacterial transmission. Heliyon 2019, 5, e01629. [Google Scholar] [CrossRef] [PubMed]
  68. Janezic, S.; Mlakar, S.; Rupnik, M. Dissemination of Clostridium difficile spores between environment and households: Dog paws and shoes. Zoonoses Public Health 2018, 65, 669–674. [Google Scholar] [CrossRef] [PubMed]
  69. Cautivo-Reyes, K.; Knight, D.R.; Bowie, D.; Moreira-Grez, B.; Whiteley, A.S.; Riley, T.V. Biogeographic distribution and molecular epidemiology of Clostridioides (Clostridium) difficile in Western Australian soils. Appl. Environ. Microbiol. 2023, 89, e0037923. [Google Scholar] [CrossRef]
  70. Lim, S.; Hain-Saunders, N.M.R.; Imwattana, K.; Putsathit, P.; Collins, D.A.; Riley, T.V. Genetically related Clostridium difficile from water sources and human CDI cases revealed by whole-genome sequencing. Environ. Microbiol. 2022, 24, 1221–1230. [Google Scholar] [CrossRef]
  71. Janezic, S.; Potocnik, M.; Zidaric, V.; Rupnik, M. Highly Divergent Clostridium difficile Strains Isolated from the Environment. PLoS ONE 2016, 11, e0167101. [Google Scholar] [CrossRef]
  72. Chisholm, J.M.; Putsathit, P.; Riley, T.V.; Lim, S.-C. Spore-Forming Clostridium (Clostridioides) difficile in Wastewater Treatment Plants in Western Australia. Microbiol. Spectr. 2023, 11, e0358222. [Google Scholar] [CrossRef]
  73. Blau, K.; Berger, F.K.; Mellmann, A.; Gallert, C. Clostridioides difficile from Fecally Contaminated Environmental Sources: Resistance and Genetic Relatedness from a Molecular Epidemiological Perspective. Microorganisms 2023, 11, 2497. [Google Scholar] [CrossRef] [PubMed]
  74. Shivaperumal, N.; Chang, B.J.; Riley, T.V. High Prevalence of Clostridium difficile in Home Gardens in Western Australia. Appl. Environ. Microbiol. 2020, 87, e01572-20. [Google Scholar] [CrossRef]
  75. Usui, M.; Kawakura, M.; Yoshizawa, N.; San, L.L.; Nakajima, C.; Suzuki, Y.; Tamura, Y. Survival and prevalence of Clostridium difficile in manure compost derived from pigs. Anaerobe 2017, 43, 15–20. [Google Scholar] [CrossRef]
  76. Lim, S.; Knight, D.R.; Moono, P.; Foster, N.F.; Riley, T.V. Clostridium difficile in soil conditioners, mulches and garden mixes with evidence of a clonal relationship with historical food and clinical isolates. Environ. Microbiol. Rep. 2020, 12, 672–680. [Google Scholar] [CrossRef]
  77. Alam, M.J.; Anu, A.; Walk, S.T.; Garey, K.W. Investigation of potentially pathogenic Clostridium difficile contamination in household environs. Anaerobe 2014, 27, 31–33. [Google Scholar] [CrossRef] [PubMed]
  78. Le Maréchal, C.; Gateau, C.; Poezevara, T.; Couturier, J.; Rouxel, S.; Zaidi, R.S.; Houard, E.; Pourcher, A.-M.; Denis, M.; Barbut, F. Characterization of Clostridioides difficile strains isolated from manure and digestate in five agricultural biogas plants. Anaerobe 2020, 62, 102180. [Google Scholar] [CrossRef] [PubMed]
  79. Werner, A.; Mölling, P.; Fagerström, A.; Dyrkell, F.; Arnellos, D.; Johansson, K.; Sundqvist, M.; Norén, T. Whole genome sequencing of Clostridioides difficile PCR ribotype 046 suggests transmission between pigs and humans. PLoS ONE 2020, 15, e0244227. [Google Scholar] [CrossRef] [PubMed]
  80. Villagómez-Estrada, S.; Blanco, J.L.; Melo-Duran, D.; Martín, C.; Harmanus, C.; Kuijper, E.J.; García, M.E. Detection of Clostridium difficile in the environment in a veterinary teaching hospital. Anaerobe 2019, 57, 55–58. [Google Scholar] [CrossRef] [PubMed]
  81. Wojtacka, J.; Wysok, B.; Kocuvan, A.; Rupnik, M. High contamination rates of shoes of veterinarians, veterinary support staff and veterinary students with Clostridioides difficile spores. Transbound. Emerg. Dis. 2022, 69, 685–693. [Google Scholar] [CrossRef] [PubMed]
  82. Orden, C.; Neila, C.; Blanco, J.L.; Álvarez-Pérez, S.; Harmanus, C.; Kuijper, E.J.; García, M.E. Recreational sandboxes for children and dogs can be a source of epidemic ribotypes of Clostridium difficile. Zoonoses Public Health 2018, 65, 88–95. [Google Scholar] [CrossRef] [PubMed]
  83. Moono, P.; Lim, S.C.; Riley, T.V. High prevalence of toxigenic Clostridium difficile in public space lawns in Western Australia. Sci. Rep. 2017, 7, srep41196. [Google Scholar] [CrossRef] [PubMed]
  84. Janezic, S.; Smrke, J.; Rupnik, M. Isolation of Clostridioides difficile from different outdoor sites in the domestic environment. Anaerobe 2020, 62, 102183. [Google Scholar] [CrossRef] [PubMed]
  85. Williamson, C.H.D.; Roe, C.C.; Terriquez, J.; Hornstra, H.; Lucero, S.; Nunnally, A.E.; Vazquez, A.J.; Vinocur, J.; Plude, C.; Nienstadt, L.; et al. A local-scale One Health genomic surveillance of Clostridioides difficile demonstrates highly related strains from humans, canines, and the environment. Microb. Genom. 2023, 9, 001046. [Google Scholar] [CrossRef]
  86. Numberger, D.; Riedel, T.; McEwen, G.; Nübel, U.; Frentrup, M.; Schober, I.; Bunk, B.; Spröer, C.; Overmann, J.; Grossart, H.-P.; et al. Genomic analysis of three Clostridioides difficile isolates from urban water sources. Anaerobe 2019, 56, 22–26. [Google Scholar] [CrossRef]
  87. Perumalsamy, S.; Putsathit, P.; Riley, T.V. High prevalence of Clostridium difficile in soil, mulch and lawn samples from the grounds of Western Australian hospitals. Anaerobe 2019, 60, 102065. [Google Scholar] [CrossRef] [PubMed]
  88. Edwards, A.N.; Karim, S.T.; Pascual, R.A.; Jowhar, L.M.; Anderson, S.E.; McBride, S.M. Chemical and Stress Resistances of Clostridium difficile Spores and Vegetative Cells. Front. Microbiol. 2016, 7, 1698. [Google Scholar] [CrossRef]
  89. Moradigaravand, D.; Gouliouris, T.; Ludden, C.; Reuter, S.; Jamrozy, D.; Blane, B.; Naydenova, P.; Judge, K.; Aliyu, S.H.; Hadjirin, N.F.; et al. Genomic survey of Clostridium difficile reservoirs in the East of England implicates environmental contamination of wastewater treatment plants by clinical lineages. Microb. Genom. 2018, 4, e000162. [Google Scholar] [CrossRef]
  90. Tkalec, V.; Jamnikar-Ciglenecki, U.; Rupnik, M.; Vadnjal, S.; Zelenik, K.; Biasizzo, M. Clostridioides difficile in national food surveillance, Slovenia, 2015 to 2017. Eurosurveillance 2020, 25, 32–41. [Google Scholar] [CrossRef]
  91. Heise, J.; Witt, P.; Maneck, C.; Wichmann-Schauer, H.; Maurischat, S. Prevalence and phylogenetic relationship of Clostridioides difficile strains in fresh poultry meat samples processed in different cutting plants. Int. J. Food Microbiol. 2021, 339, 109032. [Google Scholar] [CrossRef]
  92. Rahimi, E.; Jalali, M.; Weese, J.S. Prevalence of Clostridium difficile in raw beef, cow, sheep, goat, camel and buffalo meat in Iran. BMC Public Health 2014, 14, 119. [Google Scholar] [CrossRef] [PubMed]
  93. Agnoletti, F.; Arcangeli, G.; Barbanti, F.; Barco, L.; Brunetta, R.; Cocchi, M.; Conedera, G.; D’Este, L.; Drigo, I.; Spigaglia, P.; et al. Survey, characterization and antimicrobial susceptibility of Clostridium difficile from marine bivalve shellfish of North Adriatic Sea. Int. J. Food Microbiol. 2019, 298, 74–80. [Google Scholar] [CrossRef] [PubMed]
  94. Troiano, T.; Harmanus, C.; Sanders, I.M.; Pasquale, V.; Dumontet, S.; Capuano, F.; Romano, V.; Kuijper, E.J. Toxigenic Clostridium difficile PCR ribotypes in edible marine bivalve molluscs in Italy. Int. J. Food Microbiol. 2015, 208, 30–34. [Google Scholar] [CrossRef] [PubMed]
  95. Primavilla, S.; Farneti, S.; Petruzzelli, A.; Drigo, I.; Scuota, S. Contamination of hospital food with Clostridium difficile in Central Italy. Anaerobe 2019, 55, 8–10. [Google Scholar] [CrossRef] [PubMed]
  96. Tkalec, V.; Viprey, V.; Davis, G.; Janezic, S.; Sente, B.; Devos, N.; Wilcox, M.; Davies, K.; Rupnik, M.; on behalf of the COMBACTE-CDI consortium. Clostridioides difficile positivity rate and PCR ribotype distribution on retail potatoes in 12 European countries, January to June 2018. Eurosurveillance 2022, 27, 2100417. [Google Scholar] [CrossRef] [PubMed]
  97. Esfandiari, Z.; Weese, S.; Ezzatpanah, H.; Jalali, M.; Chamani, M. Occurrence of Clostridium difficile in seasoned hamburgers and seven processing plants in Iran. BMC Microbiol. 2014, 14, 283. [Google Scholar] [CrossRef] [PubMed]
  98. Tan, D.T.; Mulvey, M.R.; Zhanel, G.G.; Bay, D.C.; Reid-Smith, R.J.; Janecko, N.; Golding, G.R. A Clostridioides difficile surveillance study of Canadian retail meat samples from 2016–2018. Anaerobe 2022, 74, 102551. [Google Scholar] [CrossRef] [PubMed]
  99. Pires, R.N.; Caurio, C.F.; Saldanha, G.Z.; Martins, A.F.; Pasqualotto, A.C. Clostridium difficile contamination in retail meat products in Brazil. Braz. J. Infect. Dis. 2018, 22, 345–346. [Google Scholar] [CrossRef] [PubMed]
  100. Kwon, J.H.; Lanzas, C.; Reske, K.A.; Hink, T.; Seiler, S.M.; Bommarito, K.M.; Burnham, C.-A.D.; Dubberke, E.R. An Evaluation of Food as a Potential Source for Clostridium difficile Acquisition in Hospitalized Patients. Infect. Control Hosp. Epidemiology 2016, 37, 1401–1407. [Google Scholar] [CrossRef]
  101. Lessa, F.C.; Mu, Y.; Bamberg, W.M.; Beldavs, Z.G.; Dumyati, G.K.; Dunn, J.R.; Farley, M.M.; Holzbauer, S.M.; Meek, J.I.; Phipps, E.C.; et al. Burden of Clostridium difficile Infection in the United States. N. Engl. J. Med. 2015, 372, 825–834. [Google Scholar] [CrossRef]
  102. Srinivasa, V.R.; Hariri, R.; Frank, L.R.; Kingsley, L.; Magee, E.; Pokrywka, M.; Yassin, M.H. Hospital-associated Clostridium difficile infection and reservoirs within the hospital environment. Am. J. Infect. Control 2019, 47, 780–785. [Google Scholar] [CrossRef]
  103. Sheth, P.M.; Douchant, K.; Uyanwune, Y.; Larocque, M.; Anantharajah, A.; Borgundvaag, E.; Dales, L.; McCreight, L.; McNaught, L.; Moore, C.; et al. Evidence of transmission of Clostridium difficile in asymptomatic patients following admission screening in a tertiary care hospital. PLoS ONE 2019, 14, e0207138. [Google Scholar] [CrossRef]
  104. Knetsch, C.W.; Connor, T.R.; Mutreja, A.; van Dorp, S.M.; Sanders, I.M.; Browne, H.P.; Harris, D.; Lipman, L.; Keessen, E.C.; Corver, J.; et al. Whole genome sequencing reveals potential spread of Clostridium difficile between humans and farm animals in the Netherlands, 2002 to 2011. Eurosurveillance 2014, 19, 20954. [Google Scholar] [CrossRef] [PubMed]
  105. Rodríguez-Pallares, S.; Fernández-Palacios, P.; Jurado-Tarifa, E.; Arroyo, F.; Rodríguez-Iglesias, M.A.; Galán-Sánchez, F. Transmission of toxigenic Clostridiodes difficile between a pet dog with diarrhea and a 10-month-old infant. Anaerobe 2022, 74, 102519. [Google Scholar] [CrossRef]
  106. Rodriguez-Palacios, A.; Reid-Smith, R.J.; Staempfli, H.R.; Weese, J.S. Clostridium difficile survives minimal temperature recommended for cooking ground meats. Anaerobe 2010, 16, 540–542. [Google Scholar] [CrossRef] [PubMed]
  107. Deng, K.; Plaza-Garrido, A.; Torres, J.A.; Paredes-Sabja, D. Survival of Clostridium difficile spores at low temperatures. Food Microbiol. 2015, 46, 218–221. [Google Scholar] [CrossRef] [PubMed]
  108. Candel-Pérez, C.; Ros-Berruezo, G.; Martínez-Graciá, C. A review of Clostridioides [Clostridium] difficile occurrence through the food chain. Food Microbiol. 2019, 77, 118–129. [Google Scholar] [CrossRef]
  109. Burt, S.; Siemeling, L.; Kuijper, E.; Lipman, L. Vermin on pig farms are vectors for Clostridium difficile PCR ribotypes 078 and 045. Veter-Microbiol. 2012, 160, 256–258. [Google Scholar] [CrossRef]
  110. Knight, D.R.; Riley, T.V. Genomic Delineation of Zoonotic Origins of Clostridium difficile. Front. Public Health 2019, 7, 164. [Google Scholar] [CrossRef] [PubMed]
  111. Price, J.; Cheek, E.; Lippett, S.; Cubbon, M.; Gerding, D.N.; Sambol, S.P.; Citron, D.M.; Llewelyn, M. Impact of an intervention to control Clostridium difficile infection on hospital- and community-onset disease; an interrupted time series analysis. Clin. Microbiol. Infect. 2010, 16, 1297–1302. [Google Scholar] [CrossRef]
  112. Júnior, C.O.; Silva, R.; Lage, A.; Coura, F.; Ramos, C.; Alfieri, A.; Guedes, R.; Lobato, F. Non-toxigenic strain of Clostridioides difficile Z31 reduces the occurrence of C. difficile infection (CDI) in one-day-old piglets on a commercial pig farm. Veter- Microbiol. 2019, 231, 1–6. [Google Scholar] [CrossRef] [PubMed]
  113. Kitchin, N.; Remich, S.A.; Peterson, J.; Peng, Y.; Gruber, W.C.; Jansen, K.U.; Pride, M.W.; Anderson, A.S.; Knirsch, C.; Webber, C. A Phase 2 Study Evaluating the Safety, Tolerability, and Immunogenicity of Two 3-Dose Regimens of a Clostridium difficile Vaccine in Healthy US Adults Aged 65 to 85 Years. Clin. Infect. Dis. 2020, 70, 1–10. [Google Scholar] [CrossRef]
  114. Rodriguez-Palacios, A.; LeJeune, J.T. Moist-Heat Resistance, Spore Aging, and Superdormancy in Clostridium difficile. Appl. Environ. Microbiol. 2011, 77, 3085–3091. [Google Scholar] [CrossRef] [PubMed]
  115. Fawley, W.N.; Knetsch, C.W.; MacCannell, D.R.; Harmanus, C.; Du, T.; Mulvey, M.R.; Paulick, A.; Anderson, L.; Kuijper, E.J.; Wilcox, M.H. Development and Validation of an Internationally-Standardized, High-Resolution Capillary Gel-Based Electrophoresis PCR-Ribotyping Protocol for Clostridium difficile. PLoS ONE 2015, 10, e0118150. [Google Scholar] [CrossRef] [PubMed]
Figure 1. The One Health concept as developed by the One Health High-Level Expert Panel (OHHLEP), illustrating the interconnectedness of the environment, animals, humans, and society. Communication, collaboration, and coordination among different scientific disciplines are essential to support healthy ecosystems, humans, and animals. Available under the Creative Commons CC0 1.0 license [21].
Figure 1. The One Health concept as developed by the One Health High-Level Expert Panel (OHHLEP), illustrating the interconnectedness of the environment, animals, humans, and society. Communication, collaboration, and coordination among different scientific disciplines are essential to support healthy ecosystems, humans, and animals. Available under the Creative Commons CC0 1.0 license [21].
Microorganisms 13 00429 g001
Table 1. Presence of C. difficile in animals.
Table 1. Presence of C. difficile in animals.
Animal
Species
PrevalenceMain PCR-RibotypesCitation
Pigs0.3–92%078, 014, 126, 033, 038, 046[20,22,23,24,25,26,27,28,29,30,31,32]
Cattle0–60%033, 126, 078, 014/020, 127[2,20,26,30,33,34,35,36]
Poultry0–15.4%001, 002, 014/020, 078, 025, 084[26,37,38,39,40,41,42]
Goats, sheep0.6–10.1%126, 078, 010, 014/020, 045, 110[16,24,26,41,43,44]
Horses2.4–31.8%033, 009, 010, 014/020, 078, 126, 127[20,26,30,37,45,46,47]
Dogs2.1–26%014/020, 106, 010, 078, 012, 001[26,30,39,48,49,50,51]
Cats0–16.4%010, 009, 014/020, 106, 001[49,52,53,54]
Wildlife3.5–39.2%078, 014/020, 002, 009, 010, 027, 005, 015, 087[44,55,56,57,58,59]
Table 2. Presence of C. difficile in the environment.
Table 2. Presence of C. difficile in the environment.
EnvironmentPrevalenceMain PCR-RibotypesCitation
Natural14.4–47.3%014/020, 010, 106[69,70,71]
Livestock Farming0–91.3%078, 014/020, 126, 001, 002, 033, 046[23,32,38,41,64,75,79]
Veterinary clinic4–96%014/020, 078, 010, 009[80,81]
Urban22–60%014/020, 078, 002, 010, 009, 039[55,82,83]
Household18.9–83.3%014/020, 001, 002, 010[68,74,77,84]
Wastewater Treatment plants40–100%078, 126, 014/020, 033, 127, 001[20,41,72,73,78]
Table 3. Presence of C. difficile in foods.
Table 3. Presence of C. difficile in foods.
FoodPrevalenceMain PCR-RibotypesCitation
Meat0–25.3%078, 014/020, 001[33,36,90,91,92]
Seafood3.6–23.2%014, 078, 126, 002, 010, 018[93,94]
Dairy-011/018, 078[2]
Plant-derived (vegetables, grains)0–22.4%078, 014/020, 001, 126, 027[2,95,96,97]
(-) Data not available.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Alexiou, S.; Diakou, A.; Kachrimanidou, M. The Role of Clostridioides difficile Within the One Health Framework: A Review. Microorganisms 2025, 13, 429. https://doi.org/10.3390/microorganisms13020429

AMA Style

Alexiou S, Diakou A, Kachrimanidou M. The Role of Clostridioides difficile Within the One Health Framework: A Review. Microorganisms. 2025; 13(2):429. https://doi.org/10.3390/microorganisms13020429

Chicago/Turabian Style

Alexiou, Sotiris, Anastasia Diakou, and Melania Kachrimanidou. 2025. "The Role of Clostridioides difficile Within the One Health Framework: A Review" Microorganisms 13, no. 2: 429. https://doi.org/10.3390/microorganisms13020429

APA Style

Alexiou, S., Diakou, A., & Kachrimanidou, M. (2025). The Role of Clostridioides difficile Within the One Health Framework: A Review. Microorganisms, 13(2), 429. https://doi.org/10.3390/microorganisms13020429

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop